A narrative review of ocular surface disease considerations in the management of glaucoma  

作　　者：Nathan J.Arboleda Wen-Jeng(Melissa)Yao Alex Theventhiran Gene Kim 

机构地区：[1]Department of Ophthalmology&Visual Sciences,Albert Einstein College of Medicine,Montefiore Medical Center,Greene Medical Arts Pavilion-Henkind Institute,Bronx,NY,USA

出　　处：《Annals of Eye Science》2023年第3期33-40,共8页眼科学年鉴（英文）

摘　　要：s from those searches were screened for relevance to our review topics.Publications were included if the subjects included glaucoma patients,and if ocular surface outcomes were described.Non-English papers were excluded.Key Content and Findings:Topical glaucoma medications frequently cause adverse effects on the ocular surface,both through direct action of the medications themselves as well as through toxicity from their associated preservatives.Optimization of the ocular surface may improve medication compliance rates.Traditional surgical treatments for glaucoma,such as trabeculectomy,can exacerbate OSD by disrupting the ocular surface but can also reduce the need for chronic medications.Optimization of ocular surface health is imperative in reducing trabeculectomy complication rates,while also potentially reducing the need for trabeculectomy in patients that are able to achieve intraocular pressure control through improved drop tolerability.The introduction of MIGS represents a promising alternative to existing therapies and has been shown to alleviate the overall medication burden.It would be reasonable to assume that decreasing the medication burden could reduce OSD prevalence and severity.However,more research is needed to directly assess the extent of improvement seen after MIGS.Conclusions:A comprehensive understanding of the importance of OSD in medical and surgical management of glaucoma is essential in optimizing patient care and improving outcomes.

关 键 词：GLAUCOMA ocular surface disease(OSD) dry eye minimally invasive glaucoma surgery(MIGS) TRABECULECTOMY 

分 类 号：R775[医药卫生—眼科]